Comprehensive Trends and Patterns of Antihypertensive Prescriptions Using a Nationwide Claims Database in Korea

References

• Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. The Lancet. 2006;367(9524):1747–1757. doi:10.1016/S0140-6736(06)68770-9
   PubMed Web of Science ®Google Scholar
• Feigin VL, Roth GA, Naghavi M, et al. Global burden of stroke and risk factors in 188 countries, during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. The Lancet Neurol. 2016;15(9):913–924. doi:10.1016/S1474-4422(16)30073-427291521
   PubMed Web of Science ®Google Scholar
• Levenson JW, Skerrett PJ, Gaziano JM. Reducing the global burden of cardiovascular disease: the role of risk factors. Prev Cardiol. 2002;5(4):188–199. doi:10.1111/j.1520-037X.2002.00564.x12417828
   PubMedGoogle Scholar
• Lee K, Park J. Burden of disease in Korea during 2000–10. J Public Health (Bangkok). 2014;36(2):225–234. doi:10.1093/pubmed/fdt056
   Web of Science ®Google Scholar
• Lee SW, Lee H-Y, Ihm SH, Park SH, Kim TH, Kim HC. Status of hypertension screening in the Korea National General Health Screening Program: a questionnaire survey on 210 screening centers in two metropolitan areas. Clin Hypertension. 2017;23(1):23. doi:10.1186/s40885-017-0075-z
   Google Scholar
• Kim HC, Cho M-C. Korea hypertension fact sheet 2018. Clin Hypertension. 2018;24(1):1–4. doi:10.1186/s40885-018-0098-0
   Google Scholar
• Armstrong C. JNC8 guidelines for the management of hypertension in adults. Am Fam Physician. 2014;90(7):503–504.25369633
   PubMed Web of Science ®Google Scholar
• Lee H-Y, Shin J, Kim G-H, et al. 2018 Korean Society of Hypertension Guidelines for the management of hypertension: part II-diagnosis and treatment of hypertension. Clin Hypertension. 2019;25(1):20. doi:10.1186/s40885-019-0124-x
   PubMed Web of Science ®Google Scholar
• Grol R, Grimshaw J. From best evidence to best practice: effective implementation of change in patients’ care. The Lancet. 2003;362(9391):1225–1230. doi:10.1016/S0140-6736(03)14546-1
   PubMed Web of Science ®Google Scholar
• Jackson R, Bellamy M. Antihypertensive drugs. Continuing Educ Anaesthesia Crit Care Pain. 2015;15(6):280–285.
   Google Scholar
• Kim SH, Shin DW, Kim S, et al. Prescribing Patterns of antihypertensives for treatment-naïve patients in South Korea: from Korean NHISS claim data. Int J Hypertens. 2019;2019.
   Web of Science ®Google Scholar
• Ohishi M, Yoshida T, Oh A, et al. Analysis of antihypertensive treatment using real-world Japanese data—the retrospective study of antihypertensives for lowering blood pressure (REAL) study. Hypertension Res. 2019;42(7):1057–1067. doi:10.1038/s41440-019-0238-2
   PubMed Web of Science ®Google Scholar
• Ishida T, Oh A, Hiroi S, Shimasaki Y, Nishigaki N, Tsuchihashi T. Treatment patterns and adherence to antihypertensive combination therapies in Japan using a claims database. Hypertension Res. 2019;42(2):249–256. doi:10.1038/s41440-018-0127-0
   PubMed Web of Science ®Google Scholar
• Lee J, Lee JS, Park S-H, Shin SA, Kim K. Cohort profile: the national health insurance service–national sample cohort (NHIS-NSC), South Korea. Int J Epidemiol. 2017;46(2):e15–e15. doi:10.1093/ije/dyv31926822938
   PubMed Web of Science ®Google Scholar
• Kim J, Yoon S, Kim L-Y, Kim D-S. Towards actualizing the value potential of Korea Health Insurance Review and Assessment (HIRA) data as a resource for health research: strengths, limitations, applications, and strategies for optimal use of HIRA data. J Korean Med Sci. 2017;32(5):718–728. doi:10.3346/jkms.2017.32.5.71828378543
   PubMed Web of Science ®Google Scholar
• Van den Broeck J, Cunningham SA, Eeckels R, Herbst K. Data cleaning: detecting, diagnosing, and editing data abnormalities. PLoS Med. 2005;2:10. doi:10.1371/journal.pmed.0020267
   Web of Science ®Google Scholar
• Hiroi S, Shimasaki Y, Kikuchi T, Otsuka Y, Iwasaki K, Ohishi M. Analysis of second-and third-line antihypertensive treatments after initial therapy with an angiotensin II receptor blocker using real-world Japanese data. Hypertension Res. 2016;39(12):907–912. doi:10.1038/hr.2016.96
   PubMed Web of Science ®Google Scholar
• Xu H, He Y, Xu L, Yan X, Dai H. Trends and patterns of five antihypertensive drug classes between 2007 and 2012 in China using hospital prescription data. Int J Clin Pharmacol Ther. 2015;53(6):430–437. doi:10.5414/CP20224325828638
   PubMed Web of Science ®Google Scholar
• Jarari N, Rao N, Peela JR, et al. A review on prescribing patterns of antihypertensive drugs. Clin Hypertension. 2015;22(1):7. doi:10.1186/s40885-016-0042-0
   PubMedGoogle Scholar
• Kim B-Y, Won JC, Lee JH, et al. Diabetes Fact Sheets in Korea, 2018: an appraisal of current status. Diabetes Metab J. 2019;43(4):487–494. doi:10.4093/dmj.2019.006731339012
   PubMed Web of Science ®Google Scholar
• The Korean Society of Nephrology (KSN). Chronic kidney disease Fact Sheet in Korea. 2018 Available from: http://www.ksn.or.kr/rang_board/list.html?num=1570&code=factsheet. Accessed 9 2018.
   Google Scholar
• Lindholm LH, Ibsen H, Dahlöf B, et al. Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. The Lancet. 2002;359(9311):1004–1010. doi:10.1016/S0140-6736(02)08090-X
   PubMed Web of Science ®Google Scholar
• Omboni S, Volpe M. Angiotensin receptor blockers versus angiotensin converting enzyme inhibitors for the treatment of arterial hypertension and the role of olmesartan. Adv Ther. 2019;36(2):278–297. doi:10.1007/s12325-018-0859-x30591990
   PubMed Web of Science ®Google Scholar
• Ah Y-M, Lee J-Y, Choi Y-J, et al. Persistence with antihypertensive medications in uncomplicated treatment-naïve patients: effects of initial therapeutic classes. J Korean Med Sci. 2015;30(12):1800–1806. doi:10.3346/jkms.2015.30.12.180026713055
   PubMed Web of Science ®Google Scholar
• Zanchetti A, Bond MG, Hennig M, et al. Calcium antagonist lacidipine slows down progression of asymptomatic carotid atherosclerosis: principal results of the European Lacidipine Study on Atherosclerosis (ELSA), a randomized, double-blind, long-term trial. Circulation. 2002;106(19):2422–2427. doi:10.1161/01.CIR.0000039288.86470.DD12417537
   PubMed Web of Science ®Google Scholar
• Lin Y, Ma L. Blood pressure lowering effect of calcium channel blockers on perioperative hypertension: a systematic review and meta-analysis. Medicine. 2018;97:48. doi:10.1097/MD.0000000000013152
   Web of Science ®Google Scholar
• Kim-Mitsuyama S, Ogawa H, Matsui K, Jinnouchi T, Jinnouchi H, Arakawa K. Differential effectiveness of ARB plus CCB therapy and high-dose ARB therapy in high-risk elderly hypertensive patients: subanalysis of the OSCAR study. Hypertension Res. 2015;38(3):199–207. doi:10.1038/hr.2014.164
   Web of Science ®Google Scholar
• Bakris GL. Combined therapy with a calcium channel blocker and an angiotensin II type 1 receptor blocker. J Clin Hypertens. 2008;10:27–32. doi:10.1111/j.1524-6175.2007.08029.x
   PubMed Web of Science ®Google Scholar
• Boutouyrie P, Achouba A, Trunet P, Laurent S. Amlodipine-valsartan combination decreases central systolic blood pressure more effectively than the amlodipine-atenolol combination: the EXPLOR study. Hypertension. 2010;55(6):1314–1322. doi:10.1161/HYPERTENSIONAHA.109.14899920404219
   PubMed Web of Science ®Google Scholar
• Saruta T, Ogihara T, Saito I, et al. Comparison of olmesartan combined with a calcium channel blocker or a diuretic in elderly hypertensive patients (COLM Study): safety and tolerability. Hypertension Res. 2015;38(2):132–136. doi:10.1038/hr.2014.141
   Web of Science ®Google Scholar
• Kohro T, Yamazaki T, Sato H, Ohe K, Nagai R. The impact of a change in hypertension management guidelines on diuretic use in Japan: trends in antihypertensive drug prescriptions from 2005 to 2011. Hypertension Res. 2013;36(6):559–563. doi:10.1038/hr.2012.216
   PubMed Web of Science ®Google Scholar
• McDowell SE, Coleman JJ, Ferner R. Systematic review and meta-analysis of ethnic differences in risks of adverse reactions to drugs used in cardiovascular medicine. BMJ. 2006;332(7551):1177–1181. doi:10.1136/bmj.38803.528113.5516679330
   PubMed Web of Science ®Google Scholar
• Investigators O. Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med. 2008;358(15):1547–1559.18378520
   PubMed Web of Science ®Google Scholar
• Lim B, Kang E, Yoo S-H, Sunwoo S. Utilization pattern of antihypertensive medications according to comorbidities in a hospital-based family medicine practice. Korean J Fam Pract. 2017;7(4):563–568. doi:10.21215/kjfp.2017.7.4.563
   Google Scholar
• World Health Organization (WHO) Life expectancy and Healthy life expectancy data by country; 2018 Available from: https://apps.who.int/gho/data/view.main.SDG2016LEXv?lang=en. Accessed 46, 2018.
   Google Scholar
• Park JK, Lim Y-H, Kim K-S, et al. Changes in body fat distribution through menopause increase blood pressure independently of total body fat in middle-aged women: the Korean National Health and Nutrition Examination Survey 2007–2010. Hypertension Res. 2013;36(5):444–449. doi:10.1038/hr.2012.194
   Web of Science ®Google Scholar
• Janić M, Lunder M, Šabovič M. Arterial stiffness and cardiovascular therapy. Biomed Res Int. 2014;2014.
   Web of Science ®Google Scholar
• Morgan T. Effect of different antihypertensive drug classes on central aortic pressure. Am J Hypertens. 2004;17(2):118–123. doi:10.1016/j.amjhyper.2003.09.01214751652
   PubMed Web of Science ®Google Scholar
• Sung Y-N, Jang S-M, Lim D-H, Shin S-Y, Song H-J, Lee S-H. Prescribing patterns of antihypertensive drugs by outpatients with hypertension in 2007. Korean J Clin Pharm. 2009;19(2):167–179.
   Google Scholar
• Vögele A, Johansson T, Renom-Guiteras A, et al. Effectiveness and safety of beta blockers in the management of hypertension in older adults: a systematic review to help reduce inappropriate prescribing. BMC Geriatr. 2017;17(1):224. doi:10.1186/s12877-017-0575-429047367
   PubMed Web of Science ®Google Scholar
• Falkner B, Daniels SR, Flynn JT, et al. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics. 2004;114(2III):555–576.15286277
   PubMed Web of Science ®Google Scholar
• Riley M, Bluhm B. High blood pressure in children and adolescents. Am Fam Physician. 2012;85(7):693–700.22534345
   PubMed Web of Science ®Google Scholar
• Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA. 2003;289(19):2560–2571. doi:10.1001/jama.289.19.256012748199
   PubMed Web of Science ®Google Scholar
• Lee JH, Lim N-K, Cho M-C, Park H-Y. Epidemiology of heart failure in Korea: present and future. Korean Circ J. 2016;46(5):658–664. doi:10.4070/kcj.2016.46.5.65827721857
   PubMed Web of Science ®Google Scholar
• Lee S-R, Choi E-K. Prevalence of atrial fibrillation in Korean population. Int J Arrhythmia. 2017;18(4):195–204. doi:10.18501/arrhythmia.2017.030
   Google Scholar
• Kim JY, Kang K, Kang J, et al. Executive summary of stroke statistics in Korea 2018: a report from the Epidemiology Research Council of the Korean Stroke Society. J Stroke. 2019;21(1):42. doi:10.5853/jos.2018.0312530558400
   PubMed Web of Science ®Google Scholar
• Statistics KH. Korea National Health and Nutrition Examination Survey. 2017; Available from: http://knhanes.cdc.go.kr/. Accessed 820, 2020.
   Google Scholar
• White ER. Minimum time required to detect population trends: the need for long-term monitoring programs. BioScience. 2019;69(1):40–46. doi:10.1093/biosci/biy144
   Web of Science ®Google Scholar
• McCain C, Szewczyk T, Bracy Knight K. Population variability complicates the accurate detection of climate change responses. Glob Chang Biol. 2016;22(6):2081–2093. doi:10.1111/gcb.1321126725404
   PubMed Web of Science ®Google Scholar